Home » BioWorld Stock Report For Public Biotechnology Companies

BioWorld Stock Report For Public Biotechnology Companies

Jan. 10, 2005

To read more on related topics, click on one of the words below.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 14, 2025.
ASGCT 2025: Gene and cell therapies transform metabolic diseases
BioWorld Science
Metabolic disorders such as argininosuccinic and glutaric aciduria, methylmalonic acidemia, homocystinuria or primary hyperoxaluria require specific diets to...
FDA floods Noah Medical with multi-deviation warning letter
BioWorld MedTech
Companies new to the world of U.S. FDA regulation are often unaware of how detailed the agency’s inspections are, which might be the case with the...
Scorpion Therapeutics patents p53 Y220 mutant activators
BioWorld Science
Work at Scorpion Therapeutics Inc. has led to the identification of cellular tumor antigen p53 (TP53) (Y220C mutant) activators reported to be useful for the...